| ￥4100 | |
| Z06220-100 | |
|
|
|
|
|
|
|
|
|
| Species | Mouse | ||||
| Protein Construction |
|
||||
| Purity | > 95% as determined by Bis-Tris PAGE | ||||
| Endotoxin Level | Less than 1EU per μg by the LAL method. | ||||
| Expression System | HEK293 | ||||
| Theoretical Molecular Weight | 125.80 kDa (ITGA10) & 82.80 kDa (ITGB1) | ||||
| Apparent Molecular Weight | Due to glycosylation, the protein migrates to 140-170 kDa (ITGA10) & 100-130 kDa (ITGB1) based on Bis-Tris PAGE result. | ||||
| Formulation | Lyophilized from 0.22μm filtered solution in PBS (pH 7.4). | ||||
| Reconstitution | Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water. | ||||
| Storage & Stability | Upon receiving, the product remains stable up to 6 months at -20 °C or below. Upon reconstitution, the product should be stable for 3 months at -80 °C. Avoid repeated freeze-thaw cycles. |
Integrin alpha 10 beta 1 (ITGA10&ITGB1) Heterodimer, His, Mouse on Bis-Tris PAGE under reduced condition. The purity is greater than 95%. »
| Target Background | Alpha 10 beta 1 is currently known as four collagen-binding I domain-containing integrins, the others are namely alpha 1 beta 1, alpha 2 beta 1 and alpha 11 beta 1. α10β1 is likely to be expressed only by a subset of fibroblasts. |
| Synonyms | Integrin alpha 10 beta 1; ITGA10&ITGB1; α10β1 |
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.
